Skip to content

Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy

A Virtual Clinical Trial to Assess the Impact of Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03403361
Enrollment
36
Registered
2018-01-18
Start date
2018-06-01
Completion date
2022-08-11
Last updated
2024-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Cancer, Head and Neck Cancer, Lung Cancer

Brief summary

The aim of this protocol is to refine the accuracy of proton beam therapy (PT) by the use of dual energy computed tomography (DECT), in conjunction with novel iterative image reconstruction algorithms, to more precisely determine the tissue properties through which the proton beam path travels.

Interventions

DEVICESiemens Somatom Definition Edge

In addition to acquiring medically-routine datasets, each patient subject will be scanned sequentially at two or three different beam energies (80 or 90 kVp, 100 kVp, 120 kVp, and 140 kVp) as part of this research study.

DEVICEPhilips Brilliance Big Bore CT/simulator

In addition to acquiring medically-routine datasets, each patient subject will be scanned sequentially at two or three different beam energies (80 or 90 kVp, 100 kVp, 120 kVp, and 140 kVp) as part of this research study.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility Criteria: Inclusion Criteria: * Diagnosis of histologically proven primary or metastatic cancer requiring thoracic radiation therapy OR radiation therapy to the head and neck or brain * At least 18 years of age. * Planning to undergo proton or photon beam radiation therapy as part of the clinical management of the diagnosed cancer. * Able to understand and willing to sign an IRB-approved written informed consent document.

Exclusion criteria

* Implanted metallic objects in the region to be scanned excepting dental prostheses * IV or oral contrast medium within 24 hours prior to DECT image acqusition * Pregnant.

Design outcomes

Primary

MeasureTime frame
Dose Difference in 99% Planning Target Volume (PTV) Coverage Between Single Energy CT and Dual Energy CTDay 1

Countries

United States

Participant flow

Participants by arm

ArmCount
Dual-Energy CT Scan
Patients enrolling in this study will undergo additional sequential DECT scan in addition to their routine SECT or DECT scan.
36
Total36

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyNot imaged due to issues during the pandemic16

Baseline characteristics

CharacteristicDual-Energy CT Scan
Age, Continuous66.5 years
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
34 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
5 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
30 Participants
Region of Enrollment
United States
36 participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
21 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Dose Difference in 99% Planning Target Volume (PTV) Coverage Between Single Energy CT and Dual Energy CT

Time frame: Day 1

Population: 16 participants did not have imaging due to staffing changes and lack of communication during the pandemic.

ArmMeasureGroupValue (MEAN)Dispersion
Dual-Energy CT ScanDose Difference in 99% Planning Target Volume (PTV) Coverage Between Single Energy CT and Dual Energy CTHead and Neck Patients0.9 percentage relative to prescribed doseStandard Deviation 1.8
Dual-Energy CT ScanDose Difference in 99% Planning Target Volume (PTV) Coverage Between Single Energy CT and Dual Energy CTLung Patients1.0 percentage relative to prescribed doseStandard Deviation 2.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026